Assessment of exposure to pulmonary toxicants: Use of biological markers

James A. Bond, Lance A. Wallace, Siv Osterman-Golkar, George W. Lucier, Alan R Buckpitt, Rogene F. Hendersen

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The use of biological markers to determine the extent of prior exposures to a specific chemical and to predict future disease outcome holds great promise. Knowledge of the kinetics of formation and breakdown or clearance used to monitor exposures or to predict adverse health outcomes in a quantitative manner. Also required is more quantitative information on the relationship between the markers and resultant disease. Much of the detailed kinetic information must be obtained from animal studies. The use of PBPK modeling can help to integrate the kinetic data into a useful tool for extrapolation of data from high-to-low dose, between different exposure regimes, and from animal data to expected values in humans.

Original languageEnglish (US)
Pages (from-to)161-174
Number of pages14
JournalFundamental and Applied Toxicology
Volume18
Issue number2
DOIs
StatePublished - 1992

ASJC Scopus subject areas

  • Toxicology

Fingerprint Dive into the research topics of 'Assessment of exposure to pulmonary toxicants: Use of biological markers'. Together they form a unique fingerprint.

Cite this